Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen in Reducing Cigarette Craving in Smokers

Study Overview
=================
Brief Summary
-----------------
Study to determine the safety and effectiveness of Ariva® Silver Wintergreen lozenge on reducing craving for a cigarette in daily smokers.

Detailed Description
-----------------
Each subject will be given an Ariva® Silver Wintergreen lozenge or a Silver Wintergreen lozenge, which contains only silver salt, on a random basis. Once the lozenge has dissolved in the mouth, subjects will smoke one of their own cigarettes, and will answer questions about the experience and their craving for a cigarette. After a washout period, each subject will repeat the steps with the second type of lozenge.

Official Title
-----------------
A Randomized, Double-Blind, Crossover, Pilot Study to Evaluate the Safety and Efficacy of Ariva® Silver Wintergreen, a Smoking Aversive Lozenge, in Reducing Craving for a Cigarette in Daily Smokers

Conditions
-----------------
Tobacco Use Disorder, Smoking

Intervention / Treatment
-----------------
* Other: Ariva® Silver Wintergreen
* Other: Silver Wintergreen


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: healthy adult smoker smoking for at least 5 years smoking at least one (1) pack of cigarettes a day interest in quitting smoking Exclusion Criteria: known allergy to silver or silver salts pregnant or breast-feeding current drug or alcohol abuse, and/or history of drug or alcohol dependence within 3 months of study

Ages Eligible for Study
-----------------
Minimum Age: 23 Years
Maximum Age: 72 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Design Details

Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple


Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Experimental: Ariva® Silver Wintergreen<br>Subjects allow study product lozenge to dissolve in the mouth, smoke a cigarette, then answer questionnaires about the effect of the product on both their desire to smoke and on cigarette taste. | Other: Ariva® Silver Wintergreen<br>* Study product containing 6 mg silver salt and 2 mg nicotine per dissolvable lozenge, administered orally as a single dose.<br>|
| Active Comparator: Silver Wintergreen<br>Subjects allow comparator product lozenge to dissolve in the mouth, smoke a cigarette, then answer questionnaires about the effect of the product on both their desire to smoke and on cigarette taste. | Other: Silver Wintergreen<br>* Comparator product containing 6 mg silver salt and no tobacco (i.e., no nicotine), administered orally as a single dose.<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Effectiveness of Ariva® Silver Wintergreen lozenge on reducing craving for a cigarette in daily smokers | Effectiveness to be measured by the change in score on a craving questionnaire, from before to after product use. | 90 minutes | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
smoking, smokeless, aversion, nicotine, nicotine replacement